Research Officer in Medicine
The University of Queensland Diamantina Institute
The University of Queensland Diamantina Institute was established in 2007 as the sixth research institute of The University of Queensland. The aim of the Institute is to develop a better understanding of the molecular and cellular basis of disease, and to translate that understanding into practical outcomes for patients. Based at the Translational Research Institute (TRI) at the Princess Alexandra Hospital teaching campus in Brisbane, the Institute has more than 300 researchers and students who work closely with clinicians in the areas of cancer, immunology and genomic medicine.
UQDI is the largest partner in TRI, and is building major programs in Immunology, Cancer and Genomic Medicine research, with a particular focus on research aimed at development of new treatments. TRI is an Australian first and will see Australia play a leading role in international efforts to address a wide range of health issues. UQDI itself is an extremely well-equipped translational biomedical research institute, with outstanding facilities for research in animal models of disease including cutting-edge imaging technologies, human cell and molecular biology research in cancer and immunology, microbiology, and genomics research. Its close affiliation with clinical units at Princess Alexandra Hospital provides it with a significant strategic advantage in near-patient, translational research. UQDI is part of The University of Queensland, one of the top Australasian universities, and internationally is ranked in the top 100 universities in all major independent rankings. UQDI academics are part of a vibrant and highly successful academic institution optimising their chances of research success. Details of the research interests of academic staff may be accessed on the Institute’s web site at http://www.di.uq.edu.au/research.
This role will will conduct team-based and develop independent high quality research into blood cancers. The successful applicant will conduct experiments to analyse antigen-specific T cells and response to check-point blockade from individuals with blood cancer. As well as data analysis and documentation, the position involves supervision of Honours and Research Higher Degree students, publication and presentation of work. As part of a team, the appointee will collaborate and interact with immunologists, clinicians and statisticians/bioinformaticians utilising a number of core technologies including single cell sequencing and transcriptomics, flow cytometry and mass spectrometry, analysis of antigen responses in vitro and in humanised mice, proteomic analysis and structural immunology.
Applicants should possess qualifications in relevant disciplines. You should also have a strong desire to develop a successful and highly-productive research career in health behaviour, good general research skills, a strong methodological background, excellent statistical and analytic skills, very good writing abilities, and the capacity to work with multidisciplinary research teams.
The University of Queensland values diversity and inclusion.
Applications are particularly encouraged from Aboriginal and Torres Strait Islander peoples. For further information please contact our Australian Indigenous Employment Coordinator at: firstname.lastname@example.org
Applications are also encouraged from women.
This role is a full-time position; however flexible working arrangements may be negotiated.
This is a full-time, fixed term appointment at Academic level A. The remuneration package will be in the range $64,534 - $87,535 p.a., plus employer superannuation contributions of up to 17% (total package will be in the range $75,505 - $102,416 p.a.).
To discuss this role please contact Professor Maher Gandhi on +61 7 3443 8026 or email@example.com.
To submit an application for this role, use the Apply button below. All applicants must supply the following documents: Cover letter, Resume and Selection Criteria responses.
For information on completing the application process click here.
Application Closing date
Friday, 19 January 2018 11:55pm E. Australian Standard Time